MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)

MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)

In 2004–2016 we prospectively observed 59 oncohematology patients with mucormycosis; 21 children and 38 adults. The most frequent underlying diseases were acute myeloid leukemia and acute lymphoblastic leukemia (64 %); and main risk factors were сytostatic chemotherapy and allogeneic HSCT with prolo...

Full description

Bibliographic Details
Main Authors: N. N. Klimko, S. N. Khostelidi, O. V. Shadrivova, T. S. Bogomolova, Y. L. Avdeenko, A. G. Volkova, M. O. Popova, I. A. Mihailova, A. S. Kolbin, E. G. Boychenko, N. V. Medvedeva, E. I. Podoltseva, A. V. Klimovich, M. B. Belogurova, I. S. Zuzgin, O. S. Uspenskaya, V. N. Semelev, N. I. Ponomoreva, G. K. Abdilova, L. S. Zuborovskaya, B. V. Afanasiev
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Onkogematologiâ
Subjects:
acute leukemia
mucormycosis
lichtheimia corymbifera
mucor
posaconazole
rhizopus
rhizomucor
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/237

Internet

https://oncohematology.abvpress.ru/ongm/article/view/237

Similar Items